Mundra, A.; Yegiazaryan, A.; Karsian, H.; Alsaigh, D.; Bonavida, V.; Frame, M.; May, N.; Gargaloyan, A.; Abnousian, A.; Venketaraman, V.
Pathogenicity of Type I Interferons in Mycobacterium tuberculosis. Int. J. Mol. Sci. 2023, 24, 3919.
https://doi.org/10.3390/ijms24043919
AMA Style
Mundra A, Yegiazaryan A, Karsian H, Alsaigh D, Bonavida V, Frame M, May N, Gargaloyan A, Abnousian A, Venketaraman V.
Pathogenicity of Type I Interferons in Mycobacterium tuberculosis. International Journal of Molecular Sciences. 2023; 24(4):3919.
https://doi.org/10.3390/ijms24043919
Chicago/Turabian Style
Mundra, Akaash, Aram Yegiazaryan, Haig Karsian, Dijla Alsaigh, Victor Bonavida, Mitchell Frame, Nicole May, Areg Gargaloyan, Arbi Abnousian, and Vishwanath Venketaraman.
2023. "Pathogenicity of Type I Interferons in Mycobacterium tuberculosis" International Journal of Molecular Sciences 24, no. 4: 3919.
https://doi.org/10.3390/ijms24043919
APA Style
Mundra, A., Yegiazaryan, A., Karsian, H., Alsaigh, D., Bonavida, V., Frame, M., May, N., Gargaloyan, A., Abnousian, A., & Venketaraman, V.
(2023). Pathogenicity of Type I Interferons in Mycobacterium tuberculosis. International Journal of Molecular Sciences, 24(4), 3919.
https://doi.org/10.3390/ijms24043919